Chordate Medical Holding Stock Net Income
CMH Stock | 12.55 0.25 1.95% |
Chordate Medical Holding fundamentals help investors to digest information that contributes to Chordate Medical's financial success or failures. It also enables traders to predict the movement of Chordate Stock. The fundamental analysis module provides a way to measure Chordate Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chordate Medical stock.
Chordate |
Chordate Medical Holding Company Net Income Analysis
Chordate Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Chordate Medical Net Income | (19.76 M) |
Most of Chordate Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chordate Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Chordate Medical Holding reported net income of (19.76 Million). This is 105.79% lower than that of the Healthcare sector and 108.3% lower than that of the Medical Devices industry. The net income for all Sweden stocks is 103.46% higher than that of the company.
Chordate Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chordate Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chordate Medical could also be used in its relative valuation, which is a method of valuing Chordate Medical by comparing valuation metrics of similar companies.Chordate Medical is currently under evaluation in net income category among its peers.
Chordate Fundamentals
Return On Equity | -1.68 | |||
Return On Asset | -0.71 | |||
Operating Margin | (54.40) % | |||
Current Valuation | 102.78 M | |||
Shares Outstanding | 157.71 M | |||
Shares Owned By Insiders | 39.97 % | |||
Price To Book | 5.80 X | |||
Price To Sales | 3,320 X | |||
Revenue | 618.01 K | |||
Gross Profit | 1.93 M | |||
EBITDA | (16.85 M) | |||
Net Income | (19.76 M) | |||
Book Value Per Share | 0.12 X | |||
Cash Flow From Operations | (17.43 M) | |||
Earnings Per Share | (0.18) X | |||
Beta | 1.27 | |||
Market Capitalization | 80.99 M | |||
Total Asset | 31.22 M | |||
Net Asset | 31.22 M |
About Chordate Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chordate Medical Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chordate Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chordate Medical Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.